BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18854876)

  • 1. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
    Iannuzzella F; Garini G
    Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
    Cacoub P; Hausfater P; Musset L; Piette JC
    Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Agnello V
    Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
    Cacoub P
    Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in cryoglobulinemic vasculitis.
    Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
    J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
    Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
    Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed cryoglobulinemia: new concepts.
    Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; Font J
    Lupus; 2000; 9(2):83-91. PubMed ID: 10787003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy.
    Rossi D; Sciascia S; Fenoglio R; Ferro M; Baldovino S; Kamgaing J; Ventrella F; Kalikatzaros I; Viziello L; Solfietti L; Barreca A; Roccatello D
    Minerva Med; 2021 Apr; 112(2):162-174. PubMed ID: 33198442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
    Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
    Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoglobulinemia.
    Tedeschi A; Baratè C; Minola E; Morra E
    Blood Rev; 2007 Jul; 21(4):183-200. PubMed ID: 17289231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia.
    Sansonno D; Tucci FA; Troiani L; Sansonno L; Dammacco F
    Curr Med Chem; 2008; 15(2):117-26. PubMed ID: 18220767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
    Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
    Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
    Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoglobulinemia.
    Morra E
    Hematology Am Soc Hematol Educ Program; 2005; ():368-72. PubMed ID: 16304405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ; Chalk CH; Parks NE
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.